Literature DB >> 28017156

Sugar Based Biopolymers in Nanomedicine; New Emerging Era for Cancer Imaging and Therapy.

Mehmet S Eroglu1, Ebru Toksoy Oner2, Esra Cansever Mutlu2,3, Muge Sennaroglu Bostan1.   

Abstract

Since last decade, sugar based biopolymers are recognized in nanomedicine as promising materials for cancer imaging and therapy. Their durable, biocompatible and adhesive properties enable the fine tuning of their molecular weights (MW) and their miscellaneous nature makes the molecules acquire various conformations. These in turn provide effective endocytosis by cancer cell membranes that have already been programmed for internalization of different kinds of sugars. Therefore, biocompatible sugar based nanoparticles (SBNPs) are suitable for both cell-selective delivery of drugs and imaging through the human body. Recently, well known sugar-based markers have displayed superior performance to overcome tumor metastasis. Thereby, targeting strategies for cancer cells have been broadened to sugar-based markers as noticed in various clinic phases. In these studies, biopolymers such as chitosan, hyaluronic acid, mannan, dextran, levan, pectin, cyclodextrin, chondroitin sulphate, alginates, amylose and heparin are chemically functionalized and structurally designed as new biocompatible nanoparticles (NPs). The future cancer treatment strategies will mainly comprise of these multifunctional sugar based nanoparticles which combine the therapeutic agents with imaging technologies with the aim of rapid monitoring response to therapies. While each individual imaging and treatment step requires a long time period in effective treatment of diseases, these multifunctional sugar based nanoparticles will have the advantage of rapid detection, right drug efficiency evaluation and immediate interfere opportunity to some important diseases, especially rapidly progressing cancers. In this article, we evaluated synthesis, characterization and applications of main sugar based biopolymers and discussed their great promise in nano-formulations for cancer imaging and therapy. However much should be done and optimized prior to clinical applications of these nano-formulations for an efficient drug treatment without overall toxicity for getting most effective clinical results. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Biopolymer; Cancer; Imaging; Nanoparticle; Sugar; Therapy

Mesh:

Substances:

Year:  2017        PMID: 28017156     DOI: 10.2174/1568026616666161222101703

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  5 in total

1.  Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.

Authors:  Jyothi C Sistla; Shravan Morla; Al-Humaidi B Alabbas; Ravi C Kalathur; Chetna Sharon; Bhaumik B Patel; Umesh R Desai
Journal:  Carbohydr Polym       Date:  2018-10-28       Impact factor: 9.381

2.  Translocation of Oligonucleotide-Oligosaccharide Complexes into Cells of the Brain.

Authors:  N N Dygalo; T S Kalinina; D A Lanshakov
Journal:  Dokl Biochem Biophys       Date:  2018-05-19       Impact factor: 0.788

Review 3.  Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers.

Authors:  Hongli Yan; Zhifeng Xue; Jiarong Xie; Yixiao Dong; Zhe Ma; Xinru Sun; Dereje Kebebe Borga; Zhidong Liu; Jiawei Li
Journal:  Int J Nanomedicine       Date:  2019-12-31

4.  ASIA syndrome symptoms induced by gluteal biopolymer injections: Case-series and narrative review.

Authors:  Giovanni Montealegre; Rosa Uribe; María Alejandra Martínez-Ceballos; Adriana Rojas-Villarraga
Journal:  Toxicol Rep       Date:  2021-01-27

5.  A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen.

Authors:  Guanshu Liu; Sangeeta Ray Banerjee; Xing Yang; Nirbhay Yadav; Ala Lisok; Anna Jablonska; Jiadi Xu; Yuguo Li; Martin G Pomper; Peter van Zijl
Journal:  Nat Biomed Eng       Date:  2017-12-12       Impact factor: 25.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.